NM_001040142.2(SCN2A):c.4925G>C (p.Gly1642Ala) AND not provided

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Feb 11, 2023
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV003321413.1

Allele description [Variation Report for NM_001040142.2(SCN2A):c.4925G>C (p.Gly1642Ala)]

NM_001040142.2(SCN2A):c.4925G>C (p.Gly1642Ala)

Gene:

SCN2A:sodium voltage-gated channel alpha subunit 2 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

2q24.3

Genomic location:

Preferred name:

NM_001040142.2(SCN2A):c.4925G>C (p.Gly1642Ala)

HGVS:

NC_000002.12:g.165388731G>C
NG_008143.1:g.154330G>C
NM_001040142.2:c.4925G>CMANE SELECT
NM_001040143.2:c.4925G>C
NM_001371246.1:c.4925G>C
NM_001371247.1:c.4925G>C
NM_021007.3:c.4925G>C
NP_001035232.1:p.Gly1642Ala
NP_001035233.1:p.Gly1642Ala
NP_001358175.1:p.Gly1642Ala
NP_001358176.1:p.Gly1642Ala
NP_066287.2:p.Gly1642Ala
NC_000002.11:g.166245241G>C
NM_021007.2:c.4925G>C

Protein change:

G1642A

Molecular consequence:

NM_001040142.2:c.4925G>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001040143.2:c.4925G>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001371246.1:c.4925G>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001371247.1:c.4925G>C - missense variant - [Sequence Ontology: SO:0001583]
NM_021007.3:c.4925G>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:: none provided
Identifiers:: MedGen: CN517202

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV004025822	GeneDx	criteria provided, single submitter (GeneDx Variant Classification Process June 2021)	Uncertain significance (Feb 11, 2023)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV004025822

GeneDx

criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)

Uncertain significance
(Feb 11, 2023)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	yes	not provided	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From GeneDx, SCV004025822.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

Missense variants in this gene are often considered pathogenic (HGMD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This substitution is predicted to be within the intracellular loop between the S4 and S5 transmembrane segments of the fourth homologous domain.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	yes	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Aug 19, 2023

ClinVar

Relating variation to medicine